ImmunoMet Therapeutics, Inc.
ImmunoMet Therapeutics is a clinical stage biotech targeting cellular metabolism to develop novel anti-fibrotic and anti-tumor therapies. Our lead molecule, IM156, is a protein complex 1 (PC1) inhibit...load more
ImmunoMet Therapeutics, Inc.'s Basic Information
Industry
Headquarters
Houston, Alaska, United States
Website
Founded Year
2015
Specialties
FibrosisOncology
ImmunoMet Therapeutics, Inc.'s Competitors
Employee Insights
ImmunoMet Therapeutics, Inc.'s Top Employees
Chris (Young Woo) Lee
Associate Clinical Trials Manager
Phone Email
Frequently Asked Questions Regarding ImmunoMet Therapeutics, Inc.
Connect with anyone with AroundDeal today!
Whether you're looking to connect with key decision-makers or making remote or global hires, we've got you covered.
✔ GDPR aligned & CCPA compliant✔ Cancel anytime✔ 5 free contacts